» Articles » PMID: 31201693

Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients

Overview
Journal Obes Surg
Date 2019 Jun 16
PMID 31201693
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The implementation of high-resolution manometry (HRM) and the Lyon Consensus statement facilitate evaluation of gastroesophageal reflux disease and motility disorders in morbidly obese patients. Therefore, we aimed to investigate prevalence and phenotype of (borderline) GERD and esophageal motility disorders in this population.

Methods: Consecutive morbidly obese (BMI ≥ 35 kg/m) patients were offered evaluation by means of HRM, ambulatory 24-h pH impedance monitoring, endoscopy, and a clinical examination at our tertiary academic center. Data were collected prospectively.

Results: Out of 448 eligible individuals, 147 patients (females = 75, 51%) with a median age of 41.6 (33.4; 52.3) years and a BMI of 44 (40.9; 49.4) kg/m were included during the study period. The Chicago Classification revealed motility disorders in 50 (34%) patients, dominated by outflow obstruction (18.4%, n = 27) and a novel disorder (7.5%, n = 11), nicknamed jackhammer esophagus (JE). According to the Lyon Consensus, 52 (35.4%) patients had evidence of true GERD, whereas borderline GERD was noted in another 60 (40.8%). Hypersensitive esophagus was observed in 6.8% (n = 10). Sensitivity and specificity of symptoms for GERD were 53.8% and 68.4%, respectively.

Conclusions: The current gold standard of assessment revealed that the prevalence of esophageal motility disorders and (borderline) GERD is high in the morbidly obese population. Further longitudinal data are needed to delineate the natural course of novel motility disorders like JE in obesity and to identify risk factors for adverse outcomes following bariatric surgery.

Citing Articles

Update on esophageal function, acid and non-acid reflux after one-anastomosis gastric bypass (OAGB): high-resolution manometry, impedance-24-h pH-metry, and gastroscopy in a prospective mid-term study.

Felsenreich D, Vock N, Zach M, Kristo I, Jedamzik J, Bichler C Surg Endosc. 2025; .

PMID: 39966130 DOI: 10.1007/s00464-025-11606-7.


CLINICAL RELEVANCE OF ESOPHAGEAL MOTILITY DISORDERS AFTER BARIATRIC SURGERY: A PROSPECTIVE STUDY BASED ON HIGH-RESOLUTION IMPEDANCE MANOMETRY.

Difante L, Trindade E, Lopes A, Martins E, Remus I, Trindade M Arq Bras Cir Dig. 2024; 37:e1842.

PMID: 39630843 PMC: 11654458. DOI: 10.1590/0102-6720202400048e1842.


Is Endoscopic Surveillance Needed After Laparoscopic Sleeve Gastrectomy?.

Aiolfi A, Bona D, Lipham J, Bonavina L Curr Obes Rep. 2024; 13(1):183-185.

PMID: 38172480 DOI: 10.1007/s13679-023-00545-w.


Higher obesity class is associated with more severe esophageal symptoms and reflux burden but not altered motor function or contractile reserve.

Hiramoto B, Redd W, Muftah M, Jonnadula S, Okwara N, Jenkins A Neurogastroenterol Motil. 2023; 36(1):e14691.

PMID: 37849439 PMC: 10842391. DOI: 10.1111/nmo.14691.


Effect of Body Weight and Obesity on Esophageal Function.

Yang Y, Lin J, Li Y, Wei Y, Duan Z Physiol Res. 2023; 72(4):525-537.

PMID: 37795895 PMC: 10634559. DOI: 10.33549/physiolres.935067.


References
1.
Tutuian R, Vela M, Shay S, Castell D . Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003; 37(3):206-15. DOI: 10.1097/00004836-200309000-00004. View

2.
Ihara E, Muta K, Fukaura K, Nakamura K . Diagnosis and Treatment Strategy of Achalasia Subtypes and Esophagogastric Junction Outflow Obstruction Based on High-Resolution Manometry. Digestion. 2017; 95(1):29-35. DOI: 10.1159/000452354. View

3.
Tytgat G . Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol. 1996; 8(7):635-40. View

4.
Jaffin B, Knoepflmacher P, Greenstein R . High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients. Obes Surg. 1999; 9(4):390-5. DOI: 10.1381/096089299765552990. View

5.
Schauer P, Bhatt D, Kirwan J, Wolski K, Aminian A, Brethauer S . Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017; 376(7):641-651. PMC: 5451258. DOI: 10.1056/NEJMoa1600869. View